valdecoxib has been researched along with Esophageal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, HF; Guo, JW; Hao, J; Liu, JH; Liu, JR; Liu, QJ; Liu, SX; Zhang, YJ; Zuo, LF | 1 |
1 other study(ies) available for valdecoxib and Esophageal Neoplasms
| Article | Year |
|---|---|
The regulatory effect of the p38 signaling pathway on valdecoxib-induced apoptosis of the Eca109 cell line.
Topics: Apoptosis; Cell Line, Tumor; Cyclooxygenase Inhibitors; Esophageal Neoplasms; Fas Ligand Protein; fas Receptor; Humans; Isoxazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Sulfonamides | 2009 |